Related Experiment Video
Updated: Dec 10, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell
Valerio Gigantino1, Annamaria Salvati1, Giorgio Giurato1
1Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Salerno, 84081, Italy.
Abstract:
Estrogen receptor alpha (ERα) is a ligand-inducible transcription factor which mediates estrogen actions in hormone-responsive tumors and is targeted by effective anticancer therapies based on the ERα antagonist ligands, selective estrogen receptor modulators (such as Tamoxifen/TAM) or disruptors (such as Fulvestrant/ICI). Despite its importance for cancer therapy, including acquired resistance to endocrine therapy, the molecular basis of ERα response to different ligands is not fully known to date. Interaction proteomics shows great potential to identify and characterize molecular mechanisms of disease based on physical and functional protein-protein interaction networks. Tandem affinity purification coupled to mass spectrometry is applied here for mapping in hormone-responsive breast cancer cells nuclei, the ERα interactomes, induced by each of the two classes of antiestrogens. The results provide new insights on the molecular bases for antiestrogen-mediated control of ERα function and reveal new potential ways to overcome endocrine therapy resistance in cancer.
Insights
Estrogen receptor alpha (ERα) interactomes were mapped using mass spectrometry. This reveals new insights into how antiestrogens control ERα function and offers strategies to overcome endocrine therapy resistance in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Endocrinology
Background:
- Estrogen receptor alpha (ERα) is a key transcription factor in hormone-responsive tumors, targeted by therapies like Tamoxifen and Fulvestrant.
- Understanding ERα's molecular response to different ligands is crucial for effective cancer therapy and overcoming acquired resistance.
- Interaction proteomics offers a powerful approach to map protein-protein interactions and elucidate disease mechanisms.
Purpose of the Study:
- To map the ERα interactomes in hormone-responsive breast cancer cells under the influence of two distinct classes of antiestrogens.
- To gain molecular insights into how antiestrogens modulate ERα function.
- To identify potential new strategies for overcoming endocrine therapy resistance in cancer.
Main Methods:
- Utilized tandem affinity purification coupled with mass spectrometry (AP-MS).
- Focused on mapping ERα protein-protein interactions within the nuclei of hormone-responsive breast cancer cells.
- Analyzed ERα interactomes induced by two classes of antiestrogens (ERα antagonist ligands and selective estrogen receptor modulators/disruptors).
Main Results:
- Successfully mapped the ERα interactomes in response to different antiestrogens.
- Provided novel insights into the molecular mechanisms underlying antiestrogen-mediated ERα regulation.
- Identified potential protein interactions that could be targeted to enhance endocrine therapy efficacy.
Conclusions:
- The study elucidates the molecular basis of ERα control by antiestrogens.
- Findings suggest new therapeutic avenues for overcoming endocrine resistance in breast cancer.
- Interaction proteomics is a valuable tool for dissecting complex signaling pathways in cancer.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Nucleolus
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

